73
Views
155
CrossRef citations to date
0
Altmetric
Article

Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk

, , , , , & show all
Pages 1247-1253 | Received 31 Aug 2006, Accepted 27 Nov 2006, Published online: 27 Mar 2023

REFERENCES

  • Allen, J. D., A. van Loevezijn, J. M. Lakhai, M. A. van der Valk, O. van Tellingen, G. Reid, J. H. M. Schellens, G. J. Koomen, and A. H. Schinkel. 2002. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1:417–425.
  • Bardelmeijer, H. A., J. H. Beijnen, K. R. Brouwer, H. Rosing, W. J. Nooijen, J. H. M. Schellens, and O. van Tellingen. 2000. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein. Clin. Cancer Res 6:4416–4421.
  • Bosch, T. M., L. M. Kjellberg, A. Bouwers, B. P. Koeleman, J. H. M. Schellens, J. H. Beijnen, P. H. Smits, and I. Meijerman. 2005. Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population. Am. J. Pharmacogenom. 5:123–131.
  • Breedveld, P., N. Zelcer, D. Pluim, Ö. Sönmezer, M. M. Tibben, J. H. Beijnen, A. H. Schinkel, O. van Tellingen, P. Borst, and J. H. M. Schellens. 2004. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer Res 64:5804–5811.
  • Breedveld, P., J. H. Beijnen, and J. H. M. Schellens. 2006. Use of P-gp (ABCB1) and BCRP (ABCG2) inhibitors to improve oral bioavailability and brain penetration of anticancer drugs. Trends Pharmacol. Sci. 27:17–24.
  • Cohen-Zinder, M., E. Seroussi, D. M. Larkin, J. J. Loor, A. Everts-van der Wind, J. H. Lee, J. K. Drackley, M. R. Band, A. G. Hernandez, M. Shani, H. A Lewin, J. I. Weller, and M. Ron. 2005. Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle. Genome Res. 15:936–944.
  • Foraker, A. B., C. M. Khantwal, and P. W. Swaan. 2003. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv. Drug Del. Rev. 55:1467–1483.
  • Hill, M. J. 1997. Intestinal flora and endogenous vitamin synthesis. Eur. J. Cancer Prev. 6:S43–S45.
  • Huang, S., and P. W. Swaan. 2000. Involvement of a receptor-mediated component in cellular translocation of riboflavin. J. Pharmacol. Exp. Ther. 294:117–125.
  • Ifergan, I., A. Shafran, G. Jansen, J. H. Hooijberg, G. L. Scheffer, and Y. G. Assaraf. 2004. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J. Biol. Chem. 279:25527–25534.
  • Imai, Y., M. Nakane, K. Kage, S. Tsukahara, E. Ishikawa, T. Tsuruo, Y. Miki, and Y. Sugimoto. 2002. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1:611–616.
  • Jonker, J. W., M. Buitelaar, E. Wagenaar, M. A. van der Valk, G. L. Scheffer, R. J. Scheper, T. Plösch, F. Kuipers, R. P. J. Oude Elferink, H. Rosing, J. H. Beijnen, and A. H. Schinkel. 2002. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99:15649–15654.
  • Jonker, J. W., G. Merino, S. Musters, A. E. van Herwaarden, E. Bolscher, E. Wagenaar, E. Mesman, T. C. Dale, and A. H. Schinkel. 2005. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11:127–129.
  • Lichtenstein, N. S., and I. D. Goldman. 1970. Riboflavin-methotrexate interactions. Photochemical reaction and competition for transport in the L1210 mouse leukemia cell. Biochem. Pharmacol. 19:1229–1239.
  • Lowy, R. J., and K. R. Spring. 1990. Identification of riboflavin transport by MDCK cells using quantitative fluorescence video microscopy. J. Membr. Biol. 117:91–99.
  • Merino, G., A. E. van Herwaarden, E. Wagenaar, J. W. Jonker, and A. H. Schinkel. 2005. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol. Pharmacol. 67:1765–1771.
  • Powers, H. J. 2003. Riboflavin (vitamin B-2) and health. Am. J. Clin. Nutr. 77:1352–1360.
  • van Herwaarden, A. E., J. W. Jonker, E. Wagenaar, R. F. Brinkhuis, J. H. M. Schellens, J. H. Beijnen, and A. H. Schinkel. 2003. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 63:6447–6452.
  • van Herwaarden, A. E., and A. H. Schinkel. 2006. The function of breast cancer resistance protein (BCRP/ABCG2) in epithelial barriers, in stem cells and in milk secretion of drugs and xenotoxins. Trends Pharmacol. Sci. 27:10–16.
  • Yanagawa, N., R. N. G. Shih, O. D. Jo, and H. M. Said. 2000. Riboflavin transport by isolated perfused rabbit renal proximal tubules. Am. J. Physiol. Cell Physiol. 279:C1782–C1786.
  • Zamber, C. P., J. K. Lamba, K. Yasuda, J. Farnum, K. Thummel, J. D. Schuetz, and E. G. Schuetz. 2003. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13:19–28.
  • Zempleni, J. 1995. Determination of riboflavin and flavocoenzymes in human blood plasma by high-performance liquid chromatography. Ann. Nutr. Metab. 39:224–226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.